Neutralizing antibody-like PRO-001 are other therapeutic molecules which selectively inhibits the proliferation of FGFR3-transformed cells and induces apoptosis of FGFR3-expressing human myeloma cells. This evidence concerns the gene FGFR3 and plasma cell myeloma.